Health Technology Assessment Services
Evidence-aligned support to strengthen value communication and decision-ready submissions.
Inspire Pharma Consultancy supports companies in developing and executing HTA strategies that demonstrate product value, support reimbursement decisions, and enable successful market access. We integrate clinical, economic, and real-world evidence to meet HTA and payer expectations while aligning with regulatory and commercial objectives.
What We Support You With
Clinical Evidence Review & Value Dossier Support
Inspire Pharma Consultancy supports systematic review and structuring of clinical evidence to demonstrate comparative effectiveness, safety, and unmet medical need, forming a strong foundation for HTA submissions and value dossiers.
Economic Evaluation & Modeling Support
We assist in developing and reviewing economic evaluations, including cost-effectiveness, budget impact, and comparative value analyses, ensuring alignment with HTA requirements and local payer methodologies.
Real-World Evidence (RWE) & Outcomes Support
We support the identification, generation, and integration of real-world evidence to complement clinical trial data and strengthen HTA submissions, demonstrating real-life effectiveness and health system impact.
Health Technology Assessment Submission & Dossier Support
We assist in developing and reviewing economic evaluations, including cost-effectiveness, budget impact, and comparative value analyses, ensuring alignment with Health Technology Assessment requirements and local payer methodologies.
Payer & Market Access Support
We support companies in translating Health Technology Assessment outcomes into clear value messages for payers and stakeholders, facilitating informed decision-making, pricing discussions, and market access activities.
Building a Strong Value Story?
Tell us your objectives and we’ll support a structured, practical next step.